Natco Pharma (NSE:NATCOPHARM) FFO


NSE:NATCOPHARM Natco Pharma Ltd NSE:NATCOPHARM
89 GF Score
Price ₹931.40
GF Value ₹936.16
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Natco Pharma FFO?

FFO (Funds from operations) only applies to REITs.

NSE:NATCOPHARM
89GF Score
Natco Pharma Ltd NSE:NATCOPHARM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Natco Pharma (NSE:NATCOPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Natco Pharma stock appears to be undervalued. The current stock price of ₹931.40 is trading 0.5% below its estimated GF Value™ of ₹936.16. GuruFocus considers Natco Pharma to be Fairly Valued.

Key valuation signals for NSE:NATCOPHARM:

  • FFO:
  • GF Value™: ₹936.16 vs. price of ₹931.40 (0.5% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the NSE:NATCOPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natco Pharma Business Description

Other Exchanges 524816:India
Address Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.
89GF Score

Get the complete analysis for NSE:NATCOPHARM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹931.40
Price
₹936.16
GF Value